Considerations for CPX-351 in Acute Myeloid Leukemia
2 विचारों
administrator
07/04/23
Expert panelists Eunice Wang, MD; Harry Erba, MD, PhD; Alexander E. Perl, MD; and Jorge E. Cortes, MD, identify important considerations when treating acute myeloid leukemia with CPX-351, such as its toxicity profile and patient stratification.
और दिखाओ
फेसबुक टिप्पणियाँ
कोई टिप्पणी नहीं मिली